Welcome to LookChem.com Sign In|Join Free

CAS

  • or

7304-99-6

Post Buying Request

7304-99-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7304-99-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 7304-99-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,3,0 and 4 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 7304-99:
(6*7)+(5*3)+(4*0)+(3*4)+(2*9)+(1*9)=96
96 % 10 = 6
So 7304-99-6 is a valid CAS Registry Number.

7304-99-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (3-nitrophenyl) N,N-dimethylcarbamate

1.2 Other means of identification

Product number -
Other names 3-nitrophenyl dimethylcarbamate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7304-99-6 SDS

7304-99-6Relevant articles and documents

An efficient method for the protection of aromatic amines with benzostabase and its utility in anionic aromatic transformations

Lu, Erhu,Yadav, Arun,Weaver, Donald F.,Reed, Mark A.

supporting information, p. 2259 - 2262 (2013/11/06)

Herein we describe an efficient and generally applicable method of protecting a diverse series of aromatic amines with the 'benzostabase' group. We also demonstrate its efficient use in aromatic anionic chemistry including its utility in the anionic ortho

Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucoma

Harrison, Bryce A.,Whitlock, N. Andrew,Voronkov, Michael V.,Almstead, Zheng Y.,Gu, Kun-Jian,Mabon, Ross,Gardyan, Michael,Hamman, Brian D.,Allen, Jason,Gopinathan, Suma,McKnight, Beth,Crist, Mike,Zhang, Yulian,Liu, Ying,Courtney, Lawrence F.,Key, Billie,Zhou, Julia,Patel, Nita,Yates, Phil W.,Liu, Qingyun,Wilson, Alan G. E.,Kimball, S. David,Crosson, Craig E.,Rice, Dennis S.,Rawlins, David B.

supporting information; experimental part, p. 6515 - 6518 (2010/03/31)

The discovery of a pyrrolopyrimidine class of LIM-kinase 2 (LIMK2) inhibitors is reported. These LIMK2 inhibitors show good potency in enzymatic and cellular assays and good selectivity against ROCK. After topical dosing to the eye in a steroid induced mouse model of ocular hypertension, the compounds reduce intraocular pressure to baseline levels. The compounds also increase outflow facility in a pig eye perfusion assay. These results suggest LIMK2 may be an effective target for treating ocular hypertension and associated glaucoma.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7304-99-6